EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies

Heidi E Fjeldstad iD, Daniel P Jacobsen iD, Guro M Johnsen, Meryam Sugulle iD, Angel Chae iD, Sami B Kanaan iD, Hilary S Gammill, Anne Cathrine Staff iD

Acta Obstetricia et Gynecologica Scandinavica · 2023

DOI: 10.1111/aogs.14547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2023. Verfasst von Heidi E Fjeldstad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Placenta, Pre-Eclampsia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regional Health Authority of South-Eastern Norway, Oslo University Hospital, University of Oslo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transplacental fetal cell transfer results in the engraftment of fetal‐origin cells in the pregnant woman's body, a phenomenon termed fetal microchimerism. Increased fetal microchimerism measured decades postpartum is implicated in maternal inflammatory disease. Understanding which factors cause increased fetal microchimerism is therefore important. During pregnancy, circulating fetal microchimerism and placental dysfunction increase with increasing gestational age, particularly towards term. Placental dysfunction is reflected by changes in circulating placenta‐associated markers, specifically placental growth factor (PlGF), decreased by several 100 pg/mL, soluble fms‐like tyrosine kinase‐1 (sFlt‐1), increased by several 1000 pg/mL, and the sFlt‐1/PlGF ratio, increased by several 10 (pg/mL)/(pg/mL). We investigated whether such alterations in placenta‐associated markers correlate with an increase in circulating fetal‐origin cells. Material and methods We included 118 normotensive, clinically uncomplicated pregnancies (gestational age 37+1 up to 42+2 weeks‘ gestation) pre‐delivery. PlGF and sFlt‐1 (pg/mL) were measured by Elecsys® Immunoassays. We extracted DNA from maternal and fetal samples and genotyped four human leukocyte antigen loci and 17 other autosomal loci. Paternally inherited, unique fetal alleles served as polymerase chain reaction (PCR) targets for detecting fetal‐origin cells in maternal buffy coat. Fetal‐origin cell prevalence was assessed by logistic regression, and quantity by negative binomial regression. Statistical exposures included gestational age (weeks), PlGF (100 pg/mL), sFlt‐1 (1000 pg/mL) and the sFlt‐1/PlGF ratio (10 (pg/mL)/(pg/mL)). Regression models were adjusted for clinical confounders and PCR‐related competing exposures.

Results

Gestational age was positively correlated with fetal‐origin cell quantity (DRR = 2.2, P = 0.003) and PlGF was negatively correlated with fetal‐origin cell prevalence (odds ratio [OR] 100 = 0.6, P = 0.003) and quantity (DRR 100 = 0.7, P = 0.001). The sFlt‐1 and the sFlt‐1/PlGF ratios were positively correlated with fetal‐origin cell prevalence (OR 1000 = 1.3, P = 0.014 and OR 10 = 1.2, P = 0.038, respectively), but not quantity (DRR 1000 = 1.1, P = 0.600; DRR 10 = 1.1, P = 0.112, respectively).

Conclusions

Our results suggest that placental dysfunction as evidenced by placenta‐associated marker changes, may increase fetal cell transfer. The magnitudes of change tested were based on ranges in PlGF, sFlt‐1 and the sFlt‐1/PlGF ratio previously demonstrated in pregnancies near and post‐term, lending clinical significance to our findings. Our results were statistically significant after adjusting for confounders including gestational age, supporting our novel hypothesis that underlying placental dysfunction potentially is a driver of increased fetal microchimerism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaPre-EclampsiaPregnancyFemaleHumansAdultPlacenta Growth FactorPrevalenceBiomarkersPregnancy Trimester, ThirdVascular Endothelial Growth Factor Receptor-1

Stichwörter der Autor:innen

PlGFangiogenic and anti-angiogenic biomarkersfetal cell transferfetal microchimerismplacentaplacental dysfunctionplacental markerssFlt-1sFlt-1/PlGF ratio

Substanzen

Placenta Growth FactorBiomarkersVascular Endothelial Growth Factor Receptor-1

Autor:innen und Institutionen

  • Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Division of Obstetrics and Gynecology, Oslo University Hospital, Oslo, Norway.
  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Department of Obstetrics and Gynecology Research Division, University of Washington, Washington, Seattle, USA.
  • Chimerocyte, Inc., Seattle, Washington, USA.

ORCID-Profile: Heidi E Fjeldstad, Daniel P Jacobsen, Meryam Sugulle, Angel Chae, Sami B Kanaan, Anne Cathrine Staff

Förderung

  • Regional Health Authority of South-Eastern Norway
  • Oslo University Hospital
  • University of Oslo
  • Universitetet i Oslo

Zitieren

APA

Fjeldstad, H. E., Jacobsen, D. P., Johnsen, G. M., Sugulle, M., Chae, A., Kanaan, S. B., Gammill, H. S., & Staff, A. C. (2023). Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14547

Vancouver

Fjeldstad HE, Jacobsen DP, Johnsen GM, Sugulle M, Chae A, Kanaan SB, et al. Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies. Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14547

BibTeX
@article{Fjeldstad2023,
  author = {Fjeldstad, Heidi E and Jacobsen, Daniel P and Johnsen, Guro M and Sugulle, Meryam and Chae, Angel and Kanaan, Sami B and Gammill, Hilary S and Staff, Anne Cathrine},
  title = {Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2023},
  doi = {10.1111/aogs.14547}
}
Kostenlos starten →